ArticleFrontiers in pharmacology2022

Halofuginone inhibits tumor migration and invasion by affecting cancer-associated fibroblasts in oral squamous cell carcinoma.

Danni Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.